Stock Scorecard
Stock Summary for Hims & Hers Health Inc - Class A (HIMS) - $30.47 as of 1/21/2026 2:32:43 PM EST
Total Score
8 out of 30
Safety Score
32 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HIMS
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HIMS
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HIMS
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HIMS
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HIMS (32 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 1 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for HIMS
Financial Details for HIMS
Company Overview |
|
|---|---|
| Ticker | HIMS |
| Company Name | Hims & Hers Health Inc - Class A |
| Country | N/A |
| Description | Hims & Hers Health, Inc. is a leading multi-specialty telehealth platform headquartered in San Francisco, California, focused on enhancing healthcare accessibility through innovative technology. The company provides a broad spectrum of services, including telehealth consultations, prescription medications, mental health support, and a range of personal care products, effectively addressing varied healthcare needs. Positioned at the forefront of the rapidly expanding telemedicine sector, Hims & Hers is well-equipped to capitalize on the increasing consumer demand for convenient and affordable healthcare solutions. With a strong commitment to consumer-centric care and continuous expansion of its service offerings, the company is poised to adapt to evolving healthcare landscape dynamics and reinforce its significant role in the digital health market. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/23/2026 |
Stock Price History |
|
| Last Day Price | 30.47 |
| Price 4 Years Ago | 6.41 |
| Last Day Price Updated | 1/21/2026 2:32:43 PM EST |
| Last Day Volume | 15,130,865 |
| Average Daily Volume | 13,838,678 |
| 52-Week High | 72.98 |
| 52-Week Low | 23.97 |
| Last Price to 52 Week Low | 27.12% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 119.09 |
| Sector PE | 134.30 |
| 5-Year Average PE | 1.53 |
| Free Cash Flow Ratio | 19.28 |
| Industry Free Cash Flow Ratio | 15.07 |
| Sector Free Cash Flow Ratio | 24.90 |
| Current Ratio Most Recent Quarter | 1.88 |
| Total Cash Per Share | 1.58 |
| Book Value Per Share Most Recent Quarter | 2.55 |
| Price to Book Ratio | 12.27 |
| Industry Price to Book Ratio | 7.91 |
| Sector Price to Book Ratio | 8.78 |
| Price to Sales Ratio Twelve Trailing Months | 3.23 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.10 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.11 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 219,271,000 |
| Market Capitalization | 6,681,187,370 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -80.30% |
| Annual Earnings Growth | 635.28% |
| Reported EPS 12 Trailing Months | 0.53 |
| Reported EPS Past Year | 0.43 |
| Reported EPS Prior Year | 0.54 |
| Net Income Twelve Trailing Months | 133,789,000 |
| Net Income Past Year | 126,038,000 |
| Net Income Prior Year | -23,546,000 |
| Quarterly Revenue Growth YOY | 49.20% |
| 5-Year Revenue Growth | 78.03% |
| Operating Margin Twelve Trailing Months | 1.97% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 345,778,000 |
| Total Cash Past Year | 220,584,000 |
| Total Cash Prior Year | 96,663,000 |
| Net Cash Position Most Recent Quarter | -625,245,000 |
| Net Cash Position Past Year | 220,584,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 971,023,000 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 0.37 |
| Total Stockholder Equity Past Year | 476,716,000 |
| Total Stockholder Equity Prior Year | 344,029,000 |
| Total Stockholder Equity Most Recent Quarter | 580,982,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 131,537,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.60 |
| Free Cash Flow Past Year | 198,334,000 |
| Free Cash Flow Prior Year | 46,991,000 |
Options |
|
| Put/Call Ratio | 0.54 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 25.46 |
| 20-Day Bollinger Middle Band | 43.29 |
| 20-Day Bollinger Upper Band | 61.13 |
| Beta | 2.37 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 19.69 |
System |
|
| Modified | 1/20/2026 12:37:15 AM EST |